Blog
Featured post
Truveta Data leads a new era in cancer research
With more than 7 million oncology patient journeys spanning more than 100 cancer types, Truveta delivers an unprecedented breadth of regulatory grade data to support researchers in accelerating oncology therapy adoption and advancing critical cancer research.
Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
With more than 7 million oncology patient journeys spanning more than 100 cancer types, Truveta is leading a new era in cancer research, delivering an unprecedented breadth of...
Top 5 takeaways from Truveta Symposium 2025
This week we gathered with leaders across healthcare, public health, and life sciences at the 3rd annual Truveta Symposium. Truveta Symposium uniquely brings together leaders...
Women’s health: Pain medication remains rare for women receiving IUDs
Although a majority of women report intrauterine device (IUD) insertion to be moderately to severely painful, so far in 2025, only 1 in 20 women received pain medication on the...
5 ways real-world data is changing asthma research
Asthma is one of the most studied chronic diseases in medicine, yet decades into the biologics era, researchers face familiar frustrations. Limited phenotyping, unpredictable...
GLP-1 RA prescription trends: January 2018 – March 2025
Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) in March 2025 increased relative to December 2024 (+12.96%). Anti-diabetic medication (ADM) prescribing...
Study exploring syphilis infections among US adults published in American Journal of Preventative Medicine
Truveta Research explored the monthly trends in the incidence of syphilis among US adults from January 2017 and October 2024. During the early months of the COVID-19 pandemic,...
Latest trends in two-dose vaccination against measles among children in the US
The vaccination rate by age six fluctuated between 2018 and 2021; however, rates have decreased since 2021. The rate in 2021 was 81.9% compared to 80.4% in 2024. This means for...
Latest US first-time measles vaccination trends for children under 24 months
Measles vaccination rates for children under 24 months in 2024 remain lower than in 2020. In 2024, the average yearly measles vaccination rate for children by 13 months was...
Why women experience more GLP-1 side effects: New research from Olio Labs using Truveta Data
GLP-1 drugs like Ozempic and Zepbound are transforming obesity treatment, yet 40-85% of patients are plagued by adverse GI events—particularly women. New research from Olio Labs,...